Article
Mixed Views So Far on FDA Approval of Biogen's Aducanumab for Alzheimer's - 24/7 Wall St.
Rating:
0.0
Views:
61
Likes:
1
Library:
1
24/7 Wall St. has tracked multiple analyst calls regarding the expected approval or nonapproval of aducanumab as the first viable treatment against Alzheimer's disease.
Rate This Post
-
Education
-
Communication
-
Entertainment
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value